Full-Time

Imaging Technology Lead

Imaging & Digital Group, R&D

Posted on 8/15/2025

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Boston, MA, USA + 1 more

More locations: Beaconsfield, UK

Remote

Category
Medical, Clinical & Veterinary (1)
Required Skills
Data Structures & Algorithms
Requirements
  • MSc in Clinical Ultrasound (UK – or international equivalent) and/or PhD or MD in a relevant science discipline such as Medical Physics, Biomedical Engineering, Radiology, etc.
  • Strong background in clinical ultrasound or similar field
  • Experience with clinical trials involving imaging endpoints, including scanner qualification and protocol set up across different scanner vendors, centralized image core lab activities
  • Awareness of imaging applied to clinical practice
  • Proven track record of working across multiple functions with diverse teams
  • Knowledge in the scientific and clinical research of diagnostic imaging agents
  • A high degree of initiative, ability to work systematically and independently
  • Excellent communication, interpersonal skills, and teamwork
  • Excellent oral and written command of English
Responsibilities
  • Provide subject-matter expertise in imaging within PDx R&D globally
  • Advise on imaging components of clinical protocols from the standpoints of technology, quality, and practicality
  • Translate protocol imaging endpoints to an imaging strategy and formalize this in study documents including imaging manual, quality manual, site training materials and image review charter
  • Advise imaging staff at participating clinical sites
  • Author and review imaging sections of trial-facing and regulatory documents
  • Collaborate with R&D Digital colleagues in the development of novel algorithms and software tools
  • Maintain an external scientific profile, including conference presentations, publications, and consortium participation, as appropriate
  • Influence portfolio / operational strategies, technical and scientific roadmaps, risks and recommendations with internal and external teams and advise senior leadership
  • Collaborate cross-functionally within PDx clinical study teams, with medical affairs and product leaders
  • Travel to international and domestic clinical study sites to assist with or perform initiation and training
  • Maintain and develop competence in imaging modalities aligned with the R&D portfolio
  • Manage clinical study image data for internal and external customers according to Good Clinical Practice, HIPPA and other applicable regulations
  • Build cross-business strategies and collaboration between Pharmaceutical Diagnostics and other GEHC business segments
Desired Qualifications
  • Experience with other imaging modalities and contrast media
  • Relevant professional qualifications and certifications (e.g., Board Certification, Member or Fellow in an appropriate professional body etc.)
  • Experience working in industry/healthcare
  • Experience with programming languages (e.g. MATLAB, C++, Python, IDL, etc.)
  • Knowledge of commercial medical workstation platforms and their capabilities
  • Attention to detail
  • Ability to multitask
  • Ability to persevere and work effectively during high-pressure situations

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA-cleared MIM Contour ProtégéAI+ 2.0 accelerates radiation oncology planning.[1]
  • DeepHealth breast screening integration improved detection 21% in U.S. studies.
  • Intelerad strengthens cloud enterprise imaging and adjacent digital infrastructure.
  • Sonic DL and helium-free MRI can boost workflow speed and operating economics.
  • Record backlog and 2025 revenue of $20.6 billion support future software and services growth.

What critics are saying

  • Memory-chip, oil, and freight inflation already forced 2026 profit guidance lower.
  • Intelerad integration can delay cloud imaging revenue and distract sales execution.
  • FDA or clearance delays can slow AI product refreshes and MRI adoption.

What makes GE Healthcare unique

  • GE HealthCare spans imaging, ultrasound, patient care, and pharmaceutical diagnostics.[1]
  • Its 2023 spin-off created a focused, publicly traded healthcare technology company.[1]
  • The company combines hardware, software, and services across 100-plus countries.[1][3]

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at GE Healthcare who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.

INACTIVE